Compare Alcon AG (ALC) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs 10X Genomics Inc — how do they compare? Alcon AG trades at $72.52 (market cap $36.44B), while 10X Genomics Inc trades at $59.34 (market cap $7.61B). The key difference: Alcon AG is far larger — about 4.8× 10X Genomics Inc's market cap, and Alcon AG pays a 0.48% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ALC | TXG | |
|---|---|---|
Market Cap | $36.44B | $7.61B |
Sector | Health | Health |
52-Week High | $90.12 | $58.57 |
52-Week Low | $62.02 | $11.34 |
Enterprise Value | $40.28B | $7.14B |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
